结果表明接受罗格列酮治疗的患者对比对照控制组患者在心梗和心血管死亡上的优势比分别是1.43和1.64。
Results showed that rosiglitazone-treated patients had an odds ratio of 1.43 for MI and 1.64 for cardiovascular death compared with the control group.
你当时说，“我将会向前去，不断地评估，然后从有着对比对照的体验中，我将通过我的物质的意识得出结论，我将这样得出我的结论：‘是的，我选择这个。
" You said, "I will go forth, evaluate, constantly, and from the contrasting experience, I will come to conclusion through my physical awarenesses…In the saying of "Yes, I choose this.
你当时说，“我将会向前去，不断地评估，然后从有着对比对照的体验中，我将通过我的物质的意识得出结论，我将这样得出我的结论：‘是的，我选择这个。
" You said, "I will go forth, evaluate, constantly, and from the contrasting experience, I will come to conclusion through my physical awarenesses…In the saying of "Yes, I choose this.
应用推荐